Metabolite comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-06-08. Numbers and descriptions here follow the published literature rather than marketing material.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
Jeffrey Robert Bagwell (born May 27, 1968) is an American former professional baseball player and coach. A first baseman, he spent his entire 15-year Major League Baseball (MLB) playing career with the Houston Astros. Originally a Boston Red Sox fourth-round selection from the University of Hartford in the 1989 amateur draft, Bagwell was traded to the Astros in 1990. Bagwell was named the National League (NL) Rookie of the Year in 1991 and won the NL Most Valuable Player Award (MVP) in 1994. Bagwell and longtime Astros second baseman Craig Biggio and teammate Lance Berkman were known as the "Killer B's", and the team experienced consistent success during their careers; Houston finished in first or second place in the NL Central division in eleven of twelve seasons from 1994 to 2005. During that period, the Astros qualified for the playoffs six times, culminating in Bagwell's lone World Series appearance in 2005. Bagwell hit 449 home runs for the Astros, the most in club history, and set numerous other franchise career and single-season records. He is a four-time MLB All-Star, a three-time Silver Slugger winner and a Gold Glove recipient. The only player in MLB history to have six consecutive seasons (1996–2001) with thirty home runs, 100 RBIs, 100 runs scored, and 100 walks, Bagwell is one of twelve players in history to hit 400 home runs and record an on-base percentage (OBP) of .400. He is the only first baseman with at least 400 home runs and 200 stolen bases.
== Origin == In 2026, Androgenic, an Australian looksmaxxing influencer, revealed the "pentastack", a list of five substances which he uses while livestreaming. Adderall, Dextromethorphan and Ketamine are fairly common off-the-shelf pharmaceuticals with legitimate medical use. Pregabalin (under the brand name Lyrica) is a drug used to treat epilepsy and other nervous damages, and has sedative effects. 1,4-Butanediol (with street names like "Bute", "One Comma Four" or "Liquid Fantasy") is a chemical that exerts similar euphoric effects to its metabolite, GABA analogue gamma-hydroxybutyrate (GHB). BDO can cause seizures, nausea, vomiting, and withdrawal symptoms can potentially cause death.
According to British journalist Andrew Jennings, a KGB colonel stated that the agency's officers had posed as anti-doping authorities from the IOC to undermine doping tests and that Soviet athletes were "rescued with [these] tremendous efforts". On the topic of the 1980 Summer Olympics, a 1989 Australian study said "There is hardly a medal winner at the Moscow Games, certainly not a gold medal winner, who is not on one sort of drug or another: usually several kinds. The Moscow Games might as well have been called the Chemists' Games." A member of the IOC Medical Commission, Manfred Donike, privately ran additional tests with a new technique for identifying abnormal levels of testosterone by measuring its ratio to epitestosterone in urine. Twenty percent of the specimens he tested, including those from sixteen gold medalists, would have resulted in disciplinary proceedings had the tests been official. The results of Donike's unofficial tests later convinced the IOC to add his new technique to their testing protocols. The first documented case of "blood doping" occurred at the 1980 Summer Olympics as a runner was transfused with two pints of blood before winning medals in the 5000 m and 10,000 m. Documents obtained in 2016 revealed the Soviet Union's plans for a statewide doping system in track and field in preparation for the 1984 Summer Olympics in Los Angeles. Dated prior to the country's decision to boycott the Games, the document detailed the existing steroids operations of the program, along with suggestions for further enhancements.
=== Attention-deficit hyperactivity disorder === One in four people who have a substance use disorder also have attention-deficit hyperactivity disorder, which makes the treatment of both conditions more difficult. ADHD is associated with an increased craving for drugs. Having ADHD makes it more likely that an individual will initiate substance misuse at a younger age than their peers. They are also more likely to experience poorer outcomes, such as longer time to remission, and to have increased psychiatric complications from substance misuse. While generally stimulant medications do not seem to worsen substance use, they are known to be non-medically used in some cases. Psychosocial therapy and/or nonstimulant medications and extended release stimulants are ADHD treatment options that reduce these risks.
Sources: en.wikipedia.org
=== Films depicting Cold War espionage === Tinker Tailor Soldier Spy is a 2011 Cold War spy thriller adaptation of the 1974 John le Carré novel of the same name. It is set in London in the early 1970s and follows the hunt for a Soviet double agent at the top of the British secret service. The Spy Who Came In from the Cold is a 1965 British Cold War spy film based on the 1963 John le Carré novel. The film depicts a British agent's mission as a faux defector to East Germany to sow damaging disinformation about a powerful East German intelligence officer. Firefox is a 1982 film based on a Craig Thomas novel of the same name. The plot details an American plot to steal a highly advanced Soviet fighter aircraft (MiG-31 Firefox) which is capable of Mach 6, is invisible to radar, and carries weapons controlled by thought. The Hunt for Red October is a 1990 film based on the 1984 Tom Clancy novel of the same name about the captain of a technologically advanced Soviet ballistic missile submarine that attempts to defect to the United States. James Bond first appeared in 1953. While the primary antagonists in the majority of the novels were Soviet agents, the films were only vaguely based on the Cold War. The Bond movies followed the political climate of the time in their depictions of Soviets and "Red" Chinese.
The Straw Hats' Jolly Roger became a symbol of Gen Z protests across the world. The flag was first used in protests in Indonesia in October 2023 in Yogyakarta, during protests against the Gaza war. The flag's usage among protester increased during the August 2025 Indonesian protests, also known as the 17+8 movement, consisting of students protesting against the Indonesian House of Representatives allowance hike, and the rising costs of food and education. The usage of the Straw Hats' Jolly Roger gained attention online and spread around the world. Afterwards, other people began to use this flag as well, including the 2025 Philippine anti-corruption protests and many others. The Straw Hats were inspiring since they are "teenagers who fight against an extremely corrupt ruling class" and consistently do this on behalf of the oppressed and marginalized. One participant in the 2025–2026 Philippine anti-corruption protests said, “I don't want my son to grow up in a country full of corrupt officials. I want him to grow up in a country that is peaceful and promotes equality. These characters did not just entertain me throughout my childhood, they taught me values and morals that somewhat made me who I am today. … these fictional characters taught me something that I did not expect will be a factor on how I perceive society as a whole and on what kind of world I would like my son to grow up in.”
==== Burroughs Wellcome ==== Burroughs Wellcome & Company was founded in 1880, in London by the American pharmacists Henry Wellcome and Silas Burroughs. The Wellcome Tropical Research Laboratories opened in 1902. In the 1920s, Burroughs Wellcome established research and manufacturing facilities in Tuckahoe, New York, which served as the US headquarters until the company moved to Research Triangle Park in North Carolina in 1971. The Nobel Prize winning scientists Gertrude B. Elion and George H. Hitchings worked there and invented drugs still used many years later, such as mercaptopurine. In 1959, the Wellcome Foundation bought Cooper, McDougall & Robertson Inc to become more active in animal health. When Burroughs Wellcome decided to move its headquarters, the company selected Paul Rudolph to design its new building. The Elion-Hitchings Building "was celebrated worldwide when it was built," according to Paul Rudolph Heritage Foundation president Kelvin Dickinson. Alex Sayf Cummings of Georgia State University wrote in 2016, that the "iconic building helped define the image of RTP," saying, "Love it or hate it, Rudolph's design remains an impressively audacious creative gesture and an important part of the history of both architecture and Research Triangle Park." United Therapeutics, which bought the building in 2012, announced plans in 2020, to tear it down.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.